OUR TEAM

At Volastra, we are relentlessly committed to harnessing cutting-edge science to discover, develop and deliver novel therapies to patients. Our leadership team brings together expertise from diverse disciplines including drug discovery, clinical development, and business strategy. We are united by a shared passion to accelerate the pace of each new discovery, bridging the gap between scientific advancements and patient impact.

Charles Hugh-Jones, M.D., FRCP

Charles Hugh-Jones, M.D., FRCP

Chief Executive Officer

Scott Drutman, M.D., PH.D.

Scott Drutman, M.D., PH.D.

Chief Medical Officer, Head of Research & Development

Rachel Zolot Schwartz, MBA

Rachel Zolot Schwartz, MBA

Chief Business Officer, Head of Operations

Judy O’Hagan

Judy O’Hagan

Head of Human Resources (Consultant)

Jianmin Mao, Ph.D.

Jianmin Mao, Ph.D.

Senior Vice President, CMC

Christina Eng, Ph.D.

Christina Eng, Ph.D.

Vice President, Biology

Sarah Bettigole, Ph.D.

Sarah Bettigole, Ph.D.

Vice President, Immunology and Data Sciences

Derek Cogan, Ph.D.

Derek Cogan, Ph.D.

Vice President, Chemistry

Timothy Bowler, M.D., PH.D.

Timothy Bowler, M.D., PH.D.

Vice President, Clinical Development

SANDI PETERSON, CHAIR

Operating PartnerClayton, Dubilier & Rice

Charles Hugh-Jones, M.D., FRCP

Chief Executive OfficerVolastra Therapeutics

Ellie McGuire

PartnerPolaris Partners

SAMUEL BAKHOUM, M.D., PH.D.

Assistant MemberHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center

Arjun Balar, M.D.

Senior Vice President – Global Clinical DevelopmentLilly

Rez Halse, PH.D.

PartnerDROIA Ventures

STEFAN VITOROVIC

Co-Founder and Managing DirectorVida Ventures

David Nicholson, PH.D.

Independent Board Member

Lewis Cantley, Ph.D.

Founder and Chair of Scientific Advisory Committee Professor Of Cell Medicine And Faculty Member, Dana Farber Cancer Center

Samuel Bakhoum, M.D., PH. D.

Founder and Scientific Advisor Assistant Member, Human Oncology And Pathogenesis Program, Memorial Sloan Kettering Cancer Center

Olivier Elemento, PH.D.

Founder and Scientific AdvisorDirector Of Englander Institute For Precision Medicine, Weill Cornell Medicine

David Baltimore, PH.D.

Scientific Advisor President Emeritus And Distinguished Professor Of Biology, California Institute Of Technology

Duane Compton, PH.D.

Scientific Advisor Dean, Geisel School Of Medicine, Dartmouth College

Gerard Evan, FRS, FMedSci

Scientific Advisor Principal Group Leader, Francis Crick Institute

Tarun Kapoor, PH.D.

Scientific Advisor PELS Family Professor, Rockefeller University

David Pellman, M.D.

Scientific Advisor Margaret M. Dyson Professor Of Pediatric Oncology, Dana-Farber Cancer Institute

Karen Vousden, Ph.D.

Scientific Advisor Chief Scientist, Cancer Research UK

Nicholas A. Saccomano, Ph.D.

Strategic AdvisorFormer CSO Array Biopharma, Former SVP-CSO Pfizer Boulder